Patent details

Basic Information

Publication number:

EP2045241

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP081055527

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

Fluoro substituted cycloalkanoindoles and their use as prostaglandin D2 receptor antagonists

French Title of Invention:

Cycloalkanoindoles substitués par un fluor et leur utilisation comme antagonistes du récepteur de prostaglandine D2

German Title of Invention:

Fluoro substituierte Cycloalkanindole und deren Verwendung als Prostaglandin D2 Rezeptor Antagonisten

SPC Number:

Dates

Filing date:

22/01/2003

Grant date:

04/07/2012

EP Publication Date:

04/07/2012

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

08/04/2009

EP B1 Publication Date:

04/07/2012

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

22/01/2014

Expiration date:

22/01/2023

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

22/01/2003

 

 

Name:

Merck Canada Inc.

Address:

16711 Trans-Canada Highway, Kirkland, QC H94 3L1, Canada (CA)

Agent

Name:

MARKS & CLERK LLP

From:

20/08/2012

Address:

BP 1775, 1017, LUXEMBOURG, Luxembourg (LU)

To:

Inventor

1

Name:

Li Lianhai

Address:

Canada (CA)

2

Name:

Sturino Claudio

Address:

Canada (CA)

3

Name:

Lachance Nicolas

Address:

Canada (CA)

4

Name:

Berthelette Carl

Address:

Canada (CA)

5

Name:

Wang Zhaoyin

Address:

Canada (CA)

Priority

Priority Number:

351384 P

Priority Date:

24/01/2002

Priority Country:

United States (US)

Classification

Main IPC Class:

C07D 209/80;

Filing date	Document type	Number of pages
12/08/2022	Request For Change	1
02/09/2022	Outgoing Correspondence	56